This inventor holds 1 USPTO granted patent. Top assignee: Yale University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Kurt Schalper: Innovator in Cancer Treatment
Introduction
Kurt Schalper is a notable inventor based in Branford, CT (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on enhancing the effectiveness of immune-modulatory therapies.
Latest Patents
Kurt Schalper holds a patent for the "Prediction of response to immune-modulatory therapies." This patent outlines a method for treating cancer by utilizing immune checkpoint blockade. It also details how to select patients for treatment with immune checkpoint blockers by detecting tumors that exhibit high levels of T-lymphocytes with low levels of activation and proliferation. The patent emphasizes that the tissue sample may be obtained from a conventional biopsy, and it specifically mentions non-small cell lung cancer as one of the cancers that may benefit from this approach. He has 1 patent to his name.
Career Highlights
Kurt Schalper is affiliated with Yale University, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve patient outcomes in cancer treatment.
Collaborations
Kurt Schalper collaborates with David L Rimm, a fellow researcher, to further explore the implications of their findings in the field of oncology.
Conclusion
Kurt Schalper's innovative approach to cancer treatment through immune-modulatory therapies showcases his dedication to improving healthcare outcomes. His contributions are paving the way for more effective cancer treatments in the future.